Disposition of 1458 shares by Khayal Tamer I of TransMedics at 38.46 subject to Rule 16b-3
| TMDX Stock | USD 75.63 6.54 9.47% |
Slightly above 56% of all TransMedics' investors are looking to take a long position. The analysis of overall sentiment of trading TransMedics Group stock suggests that some investors are interested at this time. TransMedics' investing sentiment can be driven by a variety of factors including economic data, TransMedics' earnings reports, geopolitical events, and overall market trends.
TransMedics |
Filed transaction by TransMedics Group Officer: Chief Commercial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
TransMedics Fundamental Analysis
We analyze TransMedics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TransMedics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TransMedics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
TransMedics is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
TransMedics Group Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with TransMedics stock to make a market-neutral strategy. Peer analysis of TransMedics could also be used in its relative valuation, which is a method of valuing TransMedics by comparing valuation metrics with similar companies.
Peers
TransMedics Related Equities
| NARI | Inari Medical | 30.60 | ||||
| NPCE | Neuropace | 3.11 | ||||
| INSP | Inspire Medical | 3.01 | ||||
| LUNG | Pulmonx Corp | 2.14 | ||||
| PODD | Insulet | 0.79 | ||||
| INMD | InMode | 0.65 | ||||
| OFIX | Orthofix Medical | 0.46 | ||||
| MASI | Masimo | 0.39 | ||||
| DCTH | Delcath Systems | 0.08 | ||||
| CVRX | CVRx | 1.25 | ||||
| PEN | Penumbra | 1.94 | ||||
| TELA | Tela Bio | 2.41 |
Additional Tools for TransMedics Stock Analysis
When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.